Tegretol 100 mg in 5 mL Oral Suspension
RxNorm 308971
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 308971 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Tegretol 100 mg in 5 mL Oral Suspension.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
Carbamazepine 20 mg/ML Oral Suspension [Tegretol]
(Atom ID: 12364275)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
CarBAMazepine 20 mg/ML Oral Suspension [Tegretol]
(Atom ID: 12815323)
PSNPrescribable
Prescribable Name (PSN):
Tegretol 100 mg in 5 mL Oral Suspension
(Atom ID: 12815689)
SYPrescribable
Synonym (SY):
Tegretol 100 mg per 5 mL Oral Suspension
(Atom ID: 2975567)
SYPrescribable
Synonym (SY):
Tegretol 20 mg/ML Oral Suspension
(Atom ID: 1406800)
Patient Education
Carbamazepine
Carbamazepine is used alone or in combination with other medications to control certain types of seizures in people with epilepsy. It is also used to treat trigeminal neuralgia (a condition that causes facial nerve pain). Carbamazepine extended-release capsules (Equetro brand only) are also used to treat episodes of mania (frenzied, abnormally excited or irritated mood) or mixed episodes (symptoms of mania and depression that happen at the same time) in patients with bipolar I disorder (manic-depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods). Carbamazepine is in a class of medications called anticonvulsants. It works by reducing abnormal electrical activity in the brain.
[Learn More]
* Please review the disclaimer below.